{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T08:14:51Z","timestamp":1655453691319},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/tp.0000000000000399","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T10:58:53Z","timestamp":1410346733000},"page":"841-847","source":"Crossref","is-referenced-by-count":7,"title":["Daily Low-dose Tacrolimus Is a Safe and Effective Immunosuppressive Regimen During Telaprevir-based Triple Therapy for Hepatitis C Virus Recurrence After Liver Transplant"],"prefix":"10.1097","volume":"99","author":[{"given":"Angela","family":"Papadopoulos-K\u00f6hn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Achterfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Timm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Jochum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Herzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-32-20210129","first-page":"304","article-title":"Recurrence of hepatitis C after liver transplantation.","volume":"26","author":"Vinaixa","year":"2013","journal-title":"Ann Gastroenterol"},{"key":"R2-32-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2012.09.010","article-title":"Liver transplantation in the setting of chronic HCV.","volume":"26","author":"Terrault","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R3-32-20210129","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3851\/IMP2424","article-title":"The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.","volume":"17","author":"Marks","year":"2012","journal-title":"Antivir Ther"},{"key":"R5-32-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hep.24470","article-title":"Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agentsa potentially lethal cocktail.","volume":"54","author":"Charlton","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"R6-32-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/liv.12406","article-title":"Management of HCV transplant patients with triple therapy.","volume":"34","author":"Coilly","year":"2014","journal-title":"Liver Int"},{"key":"R7-32-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lt.23516","article-title":"Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis.","volume":"19","author":"Rabie","year":"2013","journal-title":"Liver Transplant"},{"key":"R8-32-20210129","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/TP.0b013e3181fa93fa","article-title":"Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.","volume":"90","author":"Berenguer","year":"2010","journal-title":"Transplantation"},{"key":"R9-32-20210129","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1013086","article-title":"Telaprevir for retreatment of HCV infection.","volume":"364","author":"Zeuzem","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-32-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jvh.12145","article-title":"Efficacy and safety of telaprevir (TVR) triple therapy in a real-life cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment.","volume":"21","author":"Werner","year":"2014","journal-title":"J Viral Hepat"},{"key":"R11-32-20210129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.","volume":"60","author":"Coilly","year":"2014","journal-title":"J Hepatol"},{"key":"R12-32-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2003.11.080","article-title":"Specific inhibition of hepatitis C virus replication by cyclosporin A.","volume":"313","author":"Nakagawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R14-32-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24443","article-title":"Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.","volume":"54","author":"Garg","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl 5","key":"R15-32-20210129","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/j.dld.2013.07.010","article-title":"Management of anaemia and other treatment complications.","volume":"45","author":"Hezode","year":"2013","journal-title":"Dig Liver Dis"},{"key":"R16-32-20210129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jvh.12170","article-title":"Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir.","volume":"21","author":"Boglione","year":"2014","journal-title":"J Viral Hepat"},{"key":"R20-32-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1756283X13515825","article-title":"Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential.","volume":"7","author":"Stedman","year":"2014","journal-title":"Ther Adv Gastroenterol"},{"key":"R21-32-20210129","first-page":"595","article-title":"Novel therapies for hepatitis Cone pill fits all Nat Rev Drug Discov.","volume":"12","author":"Manns","year":"2013","journal-title":""},{"key":"R22-32-20210129","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/ajt.12209","article-title":"Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C.","volume":"13","author":"Fontana","year":"2013","journal-title":"Am J Transplant"},{"key":"R23-32-20210129","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/TP.0000000000000076","article-title":"HCV therapy with daclatasvir, PEG-IFN, and RBV after boceprevir-based therapy failure post-liver transplantation in hyper-IgM syndrome.","volume":"97","author":"Reddy","year":"2014","journal-title":"Transplantation"},{"key":"R24-32-20210129","first-page":"32","article-title":"The beginning of the end: what is the future of interferon therapy for chronic hepatitis C Antiviral Res.","volume":"105","author":"Feld","year":"2014","journal-title":""},{"key":"R26-32-20210129","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/cid\/ciu012","article-title":"Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.","volume":"58","author":"Hill","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R27-32-20210129","first-page":"1759","article-title":"HCV reinfection after liver transplantationmanagement and first experiences with telaprevir-based triple therapy.","volume":"138","author":"Herzer","year":"2013","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:16:33Z","timestamp":1620976593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201504000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000399","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}